Login / Signup
Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes.
Daisuke Hasegawa
Osamu Nishida
Published in:
Critical care (London, England) (2019)
Keyphrases
</>
recombinant human
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
intensive care unit
acute kidney injury
peritoneal dialysis
prognostic factors
hiv infected
patient reported outcomes
septic shock
patient reported